TP53: a key gene in human cancer

Biochimie
D P Guimaraes, P Hainaut

Abstract

TP53 is mutated in most types of human cancers and is one of the most popular genes in cancer research. The p53 protein is a sensor of multiple forms of genotoxic, oncogenic and non-genotoxic stress. It suppresses growth and controls survival of stressed cells, and as such, is the focal point of selection pressures in tissues exposed to carcinogens or to oncogenic changes. Thus, the clonal expansion of cells with mutations in TP53 may be seen as the result of a selection process intrinsic to the natural history of cancer. In this review, we discuss the nature of these various forms of selection pressure. We present a hypothesis to explain why TP53 is often mutated as either an early or a late event in cancer. Furthermore, we also summarise current knowledge on the molecular consequences of mutation for loss of wild-type protein function, dominant-negative activity, and a possible gain of oncogenic function.

References

Jul 2, 1992·Nature·D P Lane
Jan 1, 1990·Genes & Development·D P Lane, S Benchimol
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F AguilarP Cerutti
Nov 1, 1995·Current Opinion in Oncology·S W Lowe
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·N A AbramovaR Li
Aug 1, 1997·The Journal of Biological Chemistry·A M FourieM J Gething
Jun 1, 1997·Environmental Health Perspectives·A Weston, J H Godbold
Aug 28, 1997·Oncogene·J PietteV Maréchal
Oct 10, 1997·Nucleic Acids Research·S BuchhopC C Harris
Dec 31, 1997·Journal of the National Cancer Institute·R MontesanoC P Wild
Jul 22, 1998·Nucleic Acids Research·J MomandJ Niland
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Y FuchsZ Ronai
Sep 10, 1998·Genes & Development·S Y FuchsZ Ronai
Sep 22, 1998·Lancet·A N RosenthalI J Jacobs
Oct 3, 1998·Trends in Biochemical Sciences·L ChinR A DePinho
Oct 9, 1998·Genes & Development·A J Giaccia, M B Kastan
Nov 21, 1998·Oncogene·S Y FuchsZ Ronai
Dec 8, 1998·The Journal of Experimental Medicine·M MüllerP H Krammer
Jan 16, 1999·Molecular and Cellular Biology·M ThomasG Matlashewski
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·D A FreedmanA J Levine
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·X W WangC C Harris
Apr 2, 1999·Seminars in Cancer Biology·W S el-Deiry
Apr 10, 1999·The Journal of Biological Chemistry·K SubbaramaiahA J Dannenberg
May 13, 1999·Nature Genetics·M T BarrettB J Reid
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·W Tao, A J Levine
Sep 1, 1999·Oncogene·K Okamoto, C Prives
Oct 3, 1999·Cancer Metastasis Reviews·P AnkerM Stroun
Dec 22, 1999·Biochemical Pharmacology·C MéplanP Hainaut
Jan 5, 2000·Science·B A FosterF Rastinejad
Jan 20, 2000·Journal of the National Cancer Institute·G D KirkR Montesano

❮ Previous
Next ❯

Citations

Dec 14, 2011·Archives of Toxicology·Sofia Pavanello, Marcello Lotti
Jul 1, 2009·Clinical & Experimental Metastasis·Wiktor SzewczukAndrzej Semczuk
Sep 1, 2009·Journal of Maxillofacial and Oral Surgery·Bhushan V JayadeAswari Sant
Jun 6, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bryant EnglandMichael Karsy
Jul 31, 2003·Mutation Research·Igor B Rogozin, Youri I Pavlov
Dec 21, 2007·The New England Journal of Medicine·M Luana PoetaWayne M Koch
May 1, 2010·Carcinogenesis·Paolo VineisJohn D Potter
Jul 16, 2004·Biology of Reproduction·Peter SutovskyBilly N Day
Sep 29, 2006·Journal of Pediatric Hematology/oncology·Paola ChabayMaría Victoria Preciado
Mar 17, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Paola ChabayMaria Victoria Preciado
Mar 22, 2007·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Shigeru SakanoKatsusuke Naito
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Toshiyuki SakaedaKatsuhiko Okumura
Oct 19, 2010·World Journal of Gastroenterology : WJG·Noushin TaghaviReza Malekzadeh
Oct 18, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Ingrid HodorovaSilvia Rybarova
Sep 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Megan WhitnallDes R Richardson
Jan 9, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Michael KarsyMeena Jhanwar-Uniyal
Jun 11, 2008·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Paola ChabayMaría Victoria Preciado
Apr 5, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Marjo HuovinenKirsi H Vähäkangas
May 8, 2007·Protein Expression and Purification·Salma Abdelmoula-SouissiRaja Mokdad-Gargouri
Feb 18, 2004·Cancer Science·Takatoshi IshikawaFumio Ide
May 20, 2003·Pharmacology & Toxicology·Raisa Serpi, Kirsi Vähäkangas
Mar 21, 2007·Pigment Cell Research·Tanja Rothhammer, Anja-Katrin Bosserhoff
Aug 22, 2008·Journal of Cutaneous Pathology·Mulazim H BukhariMumtaz Hasan
Dec 2, 2009·International Journal of Cancer. Journal International Du Cancer·Reetta HolmilaKirsti Husgafvel-Pursiainen
Nov 30, 2004·Biochimica Et Biophysica Acta·D FalkeR L Juliano
Dec 2, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Therese Sørlie
Sep 23, 2003·Molecular Carcinogenesis·P LouAnn CableCynthia A Afshari
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Nikolai N KhodarevRalph R Weichselbaum
Jan 11, 2008·International Journal of Cancer. Journal International Du Cancer·Reetta HolmilaKirsti Husgafvel-Pursiainen
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Denise P GuimarãesPierre Hainaut
Aug 2, 2014·Journal of Medical Primatology·Keiko Y PetroskyAndrew D Miller
Jan 18, 2006·Drug Metabolism and Pharmacokinetics·Toshiyuki Sakaeda
Jan 14, 2011·Cancer Biology & Therapy·Ning Chen, Vassiliki Karantza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.